NO812944L - Fremgangsmaate ved fremstilling av nye aminotiolderivater - Google Patents

Fremgangsmaate ved fremstilling av nye aminotiolderivater

Info

Publication number
NO812944L
NO812944L NO812944A NO812944A NO812944L NO 812944 L NO812944 L NO 812944L NO 812944 A NO812944 A NO 812944A NO 812944 A NO812944 A NO 812944A NO 812944 L NO812944 L NO 812944L
Authority
NO
Norway
Prior art keywords
branched
straight
group
chain
formula
Prior art date
Application number
NO812944A
Other languages
English (en)
Norwegian (no)
Inventor
Michel Snyers
Claude Gillet
Joseph Roba
Paul Niebes
George Lambelin
Albert Lenaers
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of NO812944L publication Critical patent/NO812944L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO812944A 1980-08-29 1981-08-28 Fremgangsmaate ved fremstilling av nye aminotiolderivater NO812944L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU82738A LU82738A1 (fr) 1980-08-29 1980-08-29 Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives

Publications (1)

Publication Number Publication Date
NO812944L true NO812944L (no) 1982-03-01

Family

ID=19729472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812944A NO812944L (no) 1980-08-29 1981-08-28 Fremgangsmaate ved fremstilling av nye aminotiolderivater

Country Status (18)

Country Link
JP (1) JPS5798255A (es)
AU (1) AU7465481A (es)
BE (1) BE890116A (es)
DE (1) DE3133293A1 (es)
DK (1) DK382281A (es)
ES (1) ES8307735A1 (es)
FI (1) FI812640L (es)
FR (1) FR2489325A1 (es)
GB (1) GB2083036A (es)
GR (1) GR74348B (es)
IL (1) IL63664A0 (es)
IT (1) IT1137642B (es)
LU (1) LU82738A1 (es)
NL (1) NL8103993A (es)
NO (1) NO812944L (es)
PT (1) PT73593B (es)
SE (1) SE8104958L (es)
ZA (1) ZA815912B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2505870A (en) * 1947-05-09 1950-05-02 Phillips Petroleum Co Secondary and tertiary alkylthiol amines and their production
US3337625A (en) * 1961-09-18 1967-08-22 Lilly Co Eli Amino-acetylenic compounds
US3312732A (en) * 1962-02-28 1967-04-04 Monsanto Res Corp Aminoalkyl aminoalkanethiols
US3356730A (en) * 1964-11-25 1967-12-05 Monsanto Res Corp Mercaptoalkyl oxyalkyl amines
GB1138738A (en) * 1966-12-01 1969-01-01 Eastman Kodak Co Aziridine derivatives
US3622676A (en) * 1968-11-20 1971-11-23 Constance Anthony D Alonzo Smoking suppression
CA992105A (en) * 1970-03-26 1976-06-29 Exxon Research And Engineering Company Polythioethers formed by anionic ring opening of episulfides
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
CH632906A5 (en) * 1976-08-09 1982-11-15 Givaudan & Cie Sa Use of bifunctional N,S-compounds as flavourings

Also Published As

Publication number Publication date
FI812640A7 (fi) 1982-03-01
PT73593A (fr) 1981-09-01
DE3133293A1 (de) 1982-04-08
SE8104958L (sv) 1982-03-01
FI812640L (fi) 1982-03-01
FR2489325A1 (fr) 1982-03-05
NL8103993A (nl) 1982-03-16
IL63664A0 (en) 1981-11-30
JPS5798255A (en) 1982-06-18
IT1137642B (it) 1986-09-10
GR74348B (es) 1984-06-26
ES505037A0 (es) 1983-08-16
BE890116A (fr) 1982-03-01
DK382281A (da) 1982-03-01
GB2083036A (en) 1982-03-17
ES8307735A1 (es) 1983-08-16
AU7465481A (en) 1982-03-04
PT73593B (fr) 1982-11-10
ZA815912B (en) 1982-08-25
IT8123611A0 (it) 1981-08-24
LU82738A1 (fr) 1982-05-10

Similar Documents

Publication Publication Date Title
US6147105A (en) 2-phenylindoles as antiestrogenic pharmaceutical agents
US4379150A (en) Dibenz[b,f][1,4]oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same
AU593606B2 (en) Novel phenolic thioethers and sulphoxides as inhibitors of 5-lipoxygenase
EP0139421B1 (en) Thiazolidine derivatives, their preparation and compositions containing them
US4233302A (en) Amine derivatives and pharmaceutical compositions containing them
US5010079A (en) Indolone derivatives, their preparation and their application in therapy
EP0025111B1 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
EP0682664A1 (en) Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
NO169485B (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive, substituerte benzamidderivater
US5391552A (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
FI86175B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenolderivat.
JPH072770A (ja) 新規な置換インドール類、その製造法及びそのインドール類を含有する製剤組成物
US4299769A (en) ω-Heteroaroyl(propionyl or butyryl)-L-prolines
PT98437A (pt) Processo para a preparacao de novos piperidil-eteres e tioeteres e de composicoes farmaceuticas que os contem
US6294677B1 (en) Thiopyran derivatives
EP0229370B1 (en) Guanidinobenzoic ester derivative, a process for preparing same and pharmaceutical compositions containing same
US3317538A (en) 4, 4'-diamino-butyrophenones
FR2522000A1 (fr) Nouvelles thiopyrannopyrimidines, utiles notamment comme agents hypoglycemiants, et leur fabrication
US4048322A (en) Bronchially effective xanthene-9-carboxylates
US2618637A (en) Tertiary - aminoalkyl diarylmethyl sulfones and their preparation
US4342691A (en) ω-Heteroaroyl(propionyl or butyryl)-L-prolines
WO1998042692A1 (fr) Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments
US4418079A (en) Conjugated ketone compounds in preventing platelet thrombosis
AU673073B2 (en) Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives
NZ235295A (en) Aryl-substituted methylene diphosphonate derivatives and pharmaceutical compositions